Austria vs Macau, China: The number of people with susceptibility test result for rifampicin
Austria
165
in 2021
Macau, China
193
in 2021
Austria rank
98th
Macau, China rank
95th
The number of people with susceptibility test result for rifampicin over time
- Austria
- Macau, China
How they compare
Macau, China currently reports 193 against 165 in Austria, a difference of 28.
That makes Macau, China's figure about 1.2 times Austria's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Austria ahead.
Austria ranks 98th and Macau, China ranks 95th of 155 countries.
Across the 2 decades both report, Austria averaged higher in 1 and Macau, China in 1.
Head to head by decade
| Decade | Austria | Macau, China | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 220.67 | 220.33 | 0.3333 | Austria |
| 2020s | 169 | 201 | 32 | Macau, China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Austria or Macau, China?
- Macau, China, at 193 against 165 in Austria as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Austria and Macau, China?
- 28, with Macau, China ahead.
- How many years of comparable data are there for Austria and Macau, China?
- 5 years are reported by both, from 2017 to 2021.
- How do Austria and Macau, China rank globally for the number of people with susceptibility test result for rifampicin?
- Austria ranks 98th and Macau, China ranks 95th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.